MYBS1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MYBS1 antibody; OsI_02237 antibody; Transcription factor MYBS1 antibody; Myb-related protein S1 antibody; OsMYBS1 antibody
Target Names
MYBS1
Uniprot No.

Target Background

Function
MYBS1 Antibody is a transcription activator that binds to 5'-TATCCA-3' elements in gene promoters. It strongly derepresses the sugar-repressed transcription of promoters containing SRS or 5'-TATCCA-3' elements.
Database Links
Subcellular Location
Nucleus.

Q&A

What validation methods should be used to confirm MYBS1 antibody specificity?

When validating MYBS1 antibodies, researchers should implement multiple complementary approaches:

  • Knockout/knockdown validation: Use tissues from mybs1 mutant or MYBS1-silenced plants as negative controls to confirm antibody specificity .

  • Western blot analysis: Verify a single band of expected molecular weight (~35-40 kDa depending on species).

  • Immunoprecipitation followed by mass spectrometry: This approach can definitively identify the pulled-down protein as MYBS1 .

  • Competitive binding assays: Pre-incubation with recombinant MYBS1 protein should diminish signal intensity.

  • Cross-reactivity testing: Evaluate potential cross-reactivity with related MYB proteins, particularly MYBS2, which can have opposing functions in some contexts .

Success of validation should be documented with clear positive and negative controls following initiatives like those implemented by NeuroMab, which emphasizes transparency in antibody validation protocols .

What are the optimal sample preparation techniques for MYBS1 detection in plant tissues?

Sample preparation is critical for successful MYBS1 detection:

Protocol overview:

  • Harvest plant tissues at appropriate developmental stages (consider that MYBS1 expression fluctuates with sugar availability)

  • Flash-freeze samples in liquid nitrogen immediately to preserve protein integrity

  • Grind tissues thoroughly in a pre-chilled mortar with pestle

  • Extract proteins using a buffer containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% Triton X-100

    • 1 mM EDTA

    • Protease inhibitor cocktail

    • Critical addition: Phosphatase inhibitors (e.g., 10 mM NaF, 1 mM Na₃VO₄) to preserve MYBS1 phosphorylation state

  • Centrifuge at 12,000g for 15 minutes at 4°C

  • Collect supernatant and determine protein concentration

For nuclear MYBS1 detection, include a nuclear extraction step since MYBS1 shuttles between the nucleus and cytoplasm depending on sugar availability .

How can MYBS1 antibodies be used to study sugar-dependent subcellular localization?

MYBS1 undergoes nucleus-cytoplasm shuttling in response to sugar levels. To study this dynamic localization:

Immunofluorescence protocol:

  • Fix plant tissues or cells in 4% paraformaldehyde

  • Permeabilize with 0.2% Triton X-100

  • Block with 5% BSA

  • Incubate with validated MYBS1 primary antibody (typically 1:100-1:500 dilution)

  • Wash and apply fluorophore-conjugated secondary antibody

  • Counterstain nuclei with DAPI

  • Image using confocal microscopy

Key experimental considerations:

  • Include both sugar-starved (-S) and sugar-provided (+S) conditions

  • Track kinetics by sampling at multiple timepoints after media switch

  • Consider co-visualization with MYBS2, which often shows reciprocal localization patterns

  • Include appropriate subcellular markers to confirm nuclear/cytoplasmic compartmentalization

For rigorous quantification, measure nuclear/cytoplasmic fluorescence intensity ratios across multiple cells under different conditions and timepoints .

What controls should be included when using MYBS1 antibodies in experimental workflows?

Proper controls are essential for reliable MYBS1 antibody-based experiments:

Control TypeDescriptionPurpose
Negative controlsTissues from mybs1 knockout/knockdown plantsVerify antibody specificity
Isotype controlsIrrelevant antibody of same isotype at same concentrationDetect non-specific binding
Absorption controlsPre-incubation of antibody with excess recombinant MYBS1Confirm signal is specifically due to MYBS1 recognition
Secondary antibody-only controlsOmit primary antibodyDetect non-specific secondary antibody binding
Positive controlsRecombinant MYBS1 or tissues with known high MYBS1 expressionVerify antibody functionality
Technical replicatesMultiple independent experimentsEnsure reproducibility

For research involving interactions with other proteins, include controls that verify the specificity of detected interactions, such as reverse immunoprecipitation and protein-specific knockout controls .

How can MYBS1 antibodies be used to investigate MYBS1 phosphorylation status?

MYBS1, like its related protein MYBS2, is likely a phosphoprotein with phosphorylation affecting its function. To investigate:

Recommended approach:

  • Phos-Tag immunoblotting: This specialized technique allows separation of phosphorylated and non-phosphorylated forms of MYBS1

    • Use Phos-Tag acrylamide gels that specifically retard migration of phosphorylated proteins

    • Compare migration patterns before and after treatment with λ phosphatase

    • Multiple bands suggest different phosphorylation states

  • Immunoprecipitation coupled with mass spectrometry:

    • Immunoprecipitate MYBS1 using validated antibodies

    • Digest immunoprecipitated proteins with trypsin

    • Analyze by LC-MS/MS with phosphopeptide enrichment

    • Identify specific phosphorylation sites (for MYBS2, sites at Ser53 and Ser75 were identified using this approach)

  • Phospho-specific antibodies:

    • Once phosphorylation sites are identified, phospho-specific antibodies can be generated

    • These can be used to monitor site-specific phosphorylation under different sugar conditions

Monitor phosphorylation status under different treatments (e.g., sugar starvation vs. sugar provision) to correlate modifications with functional changes in subcellular localization or transcriptional activity .

What techniques can be used to study MYBS1 interactions with other proteins using antibody-based approaches?

Understanding MYBS1 protein interactions is crucial for deciphering its regulatory mechanisms:

Methodological options:

  • Co-immunoprecipitation (Co-IP):

    • Immunoprecipitate MYBS1 using specific antibodies

    • Analyze co-precipitated proteins by immunoblotting or mass spectrometry

    • Can reveal interactions with proteins like 14-3-3 proteins (as shown for MYBS2)

    • Include RNase treatment to discriminate between direct protein interactions and RNA-mediated associations

  • Proximity ligation assay (PLA):

    • Allows visualization of protein-protein interactions in situ

    • Requires antibodies from different species for each protein

    • Generates fluorescent signal only when proteins are within ~40 nm

    • Useful for visualizing MYBS1 interactions in different subcellular compartments

  • Bimolecular fluorescence complementation (BiFC):

    • Express MYBS1 fused to one fragment of a fluorescent protein (e.g., C-terminal YFP)

    • Express potential interacting protein fused to complementary fragment (e.g., N-terminal YFP)

    • Interaction reconstitutes fluorescence

    • Method has been successfully used for studying MYB protein interactions

Document interaction dynamics under different sugar conditions to elucidate regulatory mechanisms. Consider that interactions may be phosphorylation-dependent .

How can MYBS1 antibodies be optimized for chromatin immunoprecipitation (ChIP) experiments?

ChIP is essential for studying MYBS1 binding to genomic regions like the TA-box:

ChIP optimization strategy:

  • Crosslinking optimization:

    • Test different formaldehyde concentrations (0.75-1.5%) and incubation times (10-20 minutes)

    • For plant tissues, vacuum infiltration may improve crosslinking efficiency

  • Sonication parameters:

    • Optimize to generate 200-500 bp DNA fragments

    • Monitor fragmentation efficiency by agarose gel electrophoresis

  • Antibody validation for ChIP:

    • Verify that the antibody can recognize fixed MYBS1 protein

    • Perform preliminary ChIP-qPCR on known MYBS1 target regions (e.g., α-amylase gene promoters containing TA-box)

    • Include IgG control and input samples

  • Buffer optimization:

    • Test different IP buffers to minimize background while maximizing signal

    • Consider pre-clearing chromatin with protein A/G beads

  • ChIP-seq considerations:

    • Ensure sufficient sequencing depth (≥20 million reads)

    • Include biological replicates

    • Use appropriate peak calling algorithms (e.g., MACS2)

    • Validate peaks by motif analysis (look for TA-box enrichment)

For advanced studies, consider ChIP-reChIP to investigate co-occupancy of MYBS1 with other transcription factors or histone modifications at specific genomic loci .

How can researchers distinguish between MYBS1 and its close homologs (particularly MYBS2) in antibody-based experiments?

Distinguishing between MYBS1 and MYBS2 is critical as they often play opposing roles in sugar signaling :

Differentiation strategies:

  • Epitope selection for antibody generation:

    • Target regions with low sequence homology between MYBS1 and MYBS2

    • Avoid conserved MYB domains

    • Consider using synthetic peptides from unique C-terminal regions

  • Cross-reactivity testing:

    • Perform Western blots with recombinant MYBS1 and MYBS2 proteins

    • Check for multiple bands that might indicate detection of both proteins

    • Validate using tissues from single and double knockout plants

  • Immunodepletion approach:

    • Sequential immunoprecipitation with MYBS2-specific antibodies followed by MYBS1 detection

    • This can help remove cross-reactive proteins before analysis

  • Complementary techniques:

    • Combine antibody-based detection with mass spectrometry for definitive identification

    • Use isoform-specific qRT-PCR to correlate protein levels with transcript abundance

    • Consider tagged protein expression in mutant backgrounds

When comparing experimental results with literature, note the system studied, as MYBS1 and MYBS2 functions may differ between plant species (e.g., rice vs. Arabidopsis) .

What are the best methods for generating monoclonal antibodies against MYBS1 for research applications?

Several advanced approaches can be used to generate high-quality MYBS1 antibodies:

Methodological approaches:

  • Recombinant antibody generation:

    • Utilize single B-cell receptor (BCR) cloning technology for rapid production

    • This approach can produce antigen-specific monoclonal antibodies within weeks

    • Superior to phage display libraries which often yield only a few low-affinity antibodies

  • Antigen design considerations:

    • Use full-length recombinant MYBS1 protein for initial immunization

    • Consider subsequent boosting with MYBS1-specific peptides

    • Express MYBS1 in eukaryotic systems to preserve post-translational modifications

  • Screening strategy:

    • Implement dual ELISA screening against the immunogen and cells expressing MYBS1

    • Screen approximately 1,000 clones to increase chances of obtaining useful reagents

    • Follow NeuroMab's approach of advancing ~90 positives for additional testing

  • Advanced validation:

    • Test antibodies in multiple assay contexts (Western blot, IP, IF, ChIP)

    • Validate in both native tissues and heterologous expression systems

    • Include wildtype and knockout controls

  • Recombinant antibody conversion:

    • Sequence VH and VL regions from the best hybridomas

    • Convert to recombinant format for improved reproducibility and sustainability

    • Make sequences publicly available to enhance reproducibility

This comprehensive approach, though labor-intensive, significantly increases the likelihood of generating reliable MYBS1 antibodies that perform well across multiple experimental applications .

How can MYBS1 antibodies be used to investigate differential regulation during plant stress responses?

MYBS1 is implicated in both sugar signaling and stress responses, making antibody-based studies valuable for understanding these pathways:

Experimental design:

  • Stress treatment time course:

    • Apply relevant stresses (e.g., drought, salt, heat, or sugar starvation)

    • Collect samples at multiple timepoints (0, 2, 6, 12, 24, 48 hours)

    • Track MYBS1 protein levels, modification states, and subcellular localization

  • Protein level analysis:

    • Quantitative Western blotting with appropriate loading controls

    • Consider digital ELISA for more precise quantification

    • Compare protein levels with transcript abundance to identify post-transcriptional regulation

  • Post-translational modification profiling:

    • Monitor phosphorylation status using Phos-Tag gels

    • Investigate ubiquitination status through immunoprecipitation and ubiquitin-specific antibodies

    • Assess protein stability using cycloheximide chase experiments

  • Protein complex dynamics:

    • Analyze stress-dependent changes in MYBS1 protein interactions using Co-IP

    • Size-exclusion chromatography followed by immunoblotting to detect complex formation/dissolution

    • Assess competition between MYBS1 and MYBS2 for binding partners and DNA targets

  • Target gene regulation:

    • ChIP-seq under different stress conditions to identify condition-specific binding sites

    • Correlate with transcriptome data to establish functional outcomes

    • Focus on genes involved in ABA signaling, which is affected by MYBS1 activity

This comprehensive analysis can reveal how MYBS1 functions as an integration node between sugar signaling and stress response pathways in plants.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.